• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.17%

    Idera Pharmaceuticals, Inc. (IDRA)

    -NasdaqCM
    3.89 Up 0.02(0.52%) Dec 24, 12:59PM EST
    Add to Portfolio
    Prev Close:3.87
    Open:3.87
    Bid:N/A
    Ask:4.56 x 100
    1y Target Est:7.00
    Beta:3.18
    Earnings Date:Mar 11 - Mar 16 (Est.)
    Day's Range:3.81 - 4.00
    52wk Range:1.94 - 6.87
    Volume:431,796
    Avg Vol (3m):1,394,360
    Market Cap:333.80M
    P/E (ttm):N/A
    EPS (ttm):-0.44
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IDRA

    Comparison

    Symbol% ChgMkt Cap
    IDRAUp 0.52%333.80M
    DVAXUp 1.99%403.60M
    PFEDown 0.10%197.97B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4,427.80
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.45
    Quarterly EPS Est (Dec-14) :-0.12
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback